… This study provides Class I evidence that high-dose vitamin D2 (targeting 25OHD 130–175
nM), compared to low-dose supplementation (1,000 IU/d), was not effective in reducing MRI …

… RRMS for high-dose vitamin D2 compared with low-dose vitamin D2 supplementation.
The … Thus in this study, there seemed to be no advantage from high-dose vitamin D …

… In conclusion, although no significant association between high-dose vitamin D treatment
and … Title A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis …

… randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology
2011; 77: 1611–1618. 30 Kampman MT, Steffensen LH, Mellgren SI, Jorgensen L: Effect of …

… study assessed the effect of oral high dose vitamin D intake on IL-17 levels in MS patients in
a double blind randomized clinical trial… of relapsing remitting multiple sclerosis (RRMS) were …

… The potential role of vitamin D in multiple sclerosis (… Relapsing-Remitting MS (RRMS)
Receiving Rebif Treatment (SOLAR) study to further elucidate the efficacy and safety of high-dose …

… persons with relapsing–remitting multiple sclerosis who were … In the present study,
supplementing high-dose vitamin D 3 … with high-dose vitamin D 2 (exit EDSS vitamin D 2 median 3 …

… Our results also suggest that high-dose vitamin D supplements in comparison with low-dose …
that the duration of action and potency of vitamin D2 is less than vitamin D3.[ 31 ] …

… [11] found that in patients with relapsingremitting MS, there is … Randomized trial of daily
high-dose vitamin D3 in patients … A randomized trial of high-dose vitamin D2 in relapsing-remit…

… forms of dietary vitamin D: ergocalciferol (vitamin D2) from … in patients with clinically definite
relapsing–remitting MS as … In particular, high-dose vitamin D had a statistically significant …